Singlera Genomics

Developer of next generation sequencing by methylation haplotyping approach for the detection of cancer

placeSan Diego, California, United States calendar_todayFounded 2014 groups18 employees language singleraoncology.com

Registered entities

Investor mix

16 investors on record; lead investors include Lilly Asia Ventures, Green Pine Capital Partners, Prosperico Venture, Detong Capital.

Investor typeCountShare
Venture capital531%
Private equity425%
Bank & private debt16%
Other / undisclosed638%
Coming soon